While randomized comparative trials are needed, a relatively new treatment option for upper urinary tract cancers shows promise for lowering long-term recurrence in many patients with low-grade ...
This surgery is ideal for patients who may be deemed inoperable or at high risk for open heart surgery. For patients like Ms.
The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular ...
Haemonetics (NYSE: HAE) announced today that it acquired percutaneous vessel closure device maker Vivasure Medical.
Technology incorporating artificial intelligence (AI) and electrocardiogram (EKG) testing for patients having a heart attack decreased the time to diagnose and send patients for treatment by almost 10 ...
Gasparin et al. evaluated the analytical performance of the Hilab Lens point-of-care hematology device compared to conventional hematology. The Hilab Lens demonstrated high precision, strong ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback